(2)
Access to industry-leading genomic database and real-world evidence designed to optimize trial design, site selection, clinical trial matching and translational research
BOSTON, MA, DURHAM, NC and FT. MYERS, FL / ACCESSWIRE / February 4, 2021 / Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, and NeoGenomics, Inc.(NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a strategic partnership to advance the application of precision medicine in oncology clinical trials by applying real-world genomics data to accelerate patient matching and optimize trial design, site selection, clinical development and translational research.
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Parexel Completes Separation of Parexel Informatics and Medical Imaging Business
Parexel International LLCJanuary 11, 2021 GMT
Strategic move enhances value and growth for both companies
Parexel Informatics to relaunch as Calyx
BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, today announced it has completed the separation of its Parexel Informatics and Medical Imaging business. The strategic move is designed to simplify and streamline Parexel’s business strategy and customer relationships while best positioning both organizations for continued, long-term growth and success. As part of the separation, Parexel Informatics will become Calyx.